The Definitive 2025 Guide to the Radiopharmaceutical Landscape: 55 Companies to Watch
The Radioligand Therapy (RLT) space is experiencing a period of unprecedented growth and innovation. Driven by major acquisitions, significant venture funding, and compelling clinical data, radiopharmaceuticals are rapidly moving from a niche modality to a mainstream pillar of oncology. Navigating this dynamic ecosystem requires a clear understanding of the key players, from emerging biotech […]